The low number of significantly altered protein abundances and the fact that proteins were scattered among different pathways led us to postulate that specific tumor phenotypic differences associated to BRCA1 may not be driven by proteome alterations, but by alterations in protein function through changes in ubiquitination and phosphorylation. Here, BRCA1 is linked to neoplasm.